We use cells from the patient, for the patient.

 

Our autologous cell therapy uses an individual’s cells harvested from a small amount of their own healthy skin.  The skin is minimally processed to retrieve the cells and returned to the physician to complete the transplant.  

TeVido will bring regenerative therapy to clinics around the world.   Our process evolved from our work in biofabrication and 3D bioprinting where we have focused efforts to enable physicians to treat skin pigmentation disorders, such as vitiligo and nipple areola reconstruction for breast cancer survivors.

We are still in the Research and Development phase.

Return to Home